Home
BELLUS Health

BELLUS Health Market Share Analysis for August 2026

we are dedicated to bettering thelives of patients suffering from cough and particularlypatients impacted by persistent coughing.

Health > Biotechnology and Pharmaceuticals

Domainbellushealth.com

Year Founded1993

Employees51 - 200

Annual Revenue< $1M

BELLUS Health

BELLUS Health (including company regionals)

bellushealth.com

See more website traffic and engagement information

Total visits to BELLUS Health's top domains

Understand BELLUS Health market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in BELLUS Health's top domains

Analyze BELLUS Health engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on BELLUS Health's top domains

See how BELLUS Health keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

BELLUS Health top competitors by domain

Top similar sites in August 2026, ranked by their affinity

itrlab.comCompany NameItr Laboratories CanadaEmployees201 - 500HQCanada, MontrealAnnual revenue$25M - $50MTotal visits2.1KHealth > Biotechnology and Pharmaceuticals

Top technologies used by BELLUS Health

These are the website technologies, by industry, used by BELLUS Health top domains

Widget (8)

reCAPTCHA

Payment & Currencies (7)

Cart Functionality

Social (4)

Twitter

Conversion & Analytics (3)

Google Analytics

More Technologies

10

See all

News & Signals from BELLUS Health

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBELLUS Health Inc. attends event Invest Canada '25.At Invest Canada '25, Export Development Canada hosted a VC-focused breakout featuring executives from Clutch Technologies, Solium Capital, and Bellus Health who have each played a central role in building or leading Canadian growth stories.

NewsBELLUS Health Inc. merges with GlaxoSmithKline.BELLUS Health has agreed to merge with GSK Plc.

NewsGlaxoSmithKline acquired BELLUS Health Inc. for $2B on Apr 25th '23.GSK plc (LSE/NYSE: GSK) and BELLUS Health Inc. (TSX/NASDAQ: BLU) today announced that they have entered into an agreement under which GSK will acquire BELLUS, a Canada-based, late-stage biopharmaceutical company working to better the lives of patients suffering from refractory chronic cough (RCC) for US$14.75 per share of common stock in cash representing an approximate total equity value of US$2.0 billion (£1.6 billion).